Compare Danaher Corporation (DHR) vs Five9 Inc (FIVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Five9 Inc — how do they compare? Danaher Corporation trades at $203.46 (market cap $144.67B), while Five9 Inc trades at $33.69 (market cap $2.33B). The key difference: Danaher Corporation is far larger — about 62.1× Five9 Inc's market cap, and Danaher Corporation pays a 0.78% dividend while Five9 Inc pays none. Which is the better fit depends on your goals.
| DHR | FIVN | |
|---|---|---|
Market Cap | $144.67B | $2.33B |
Sector | Health | Technology |
52-Week High | $242.05 | $34.48 |
52-Week Low | $161.91 | $13.61 |
Enterprise Value | $166.88B | $2.48B |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $204.02, down 1.65% on the day, with a bullish technical outlook supported by moving averages and a recent history of earnings beats. The company maintains strong profitability margins and positive cash flow, though revenue growth has moderated. Recent news highlights product launches and a pending acquisition of Masimo, approved by shareholders in May 2026.
The stock presents a balanced outlook with solid fundamentals and analyst support, but faces risks from integration challenges and macroeconomic pressures. Upside is supported by a consensus price target of $202.33, while valuation multiples remain elevated relative to historical norms.
FIVN trades at $33.80, up 3.59% today, near its 52-week high of $34.58. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for three consecutive quarters. Revenue growth is accelerating, with 2025 revenue reaching $1.15 billion and net income turning positive at $39.42 million, marking a significant improvement from prior losses. Recent management appointments and AI-driven subscription growth are positive catalysts.
The outlook is positive given earnings momentum and analyst support, but risks include high valuation multiples, ongoing legal scrutiny, and dependence on competitive AI adoption. With 61% of analysts rating it a Buy and a consensus target of $32.67, near-term upside appears limited, but execution on guidance could drive further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Five9 Inc
Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Read more on FIVN →
